Teladoc Health, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $16.05B | $893.5M |
| FY2022 | — | $2.31B | $918.2M |
| FY2023 | — | $2.33B | $1.12B |
| FY2024 | — | $1.49B | $1.30B |
| FY2025 | — | $1.39B | $781.1M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $16.05B | $893.5M |
| FY2022 | — | $2.31B | $918.2M |
| FY2023 | — | $2.33B | $1.12B |
| FY2024 | — | $1.49B | $1.30B |
| FY2025 | — | $1.39B | $781.1M |